Partial purification and characterization of Trichomonas vaginalis DNA topoisomerase II

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 40, Issue 5, 2009, Pages 877-885

  Sithiprom, Somphong ^a   Petmitr, Songsak ^a   Chavalitshewinkoon Petmitr, Porntip ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMSACRINE; DNA TOPOISOMERASE (ATP HYDROLYSING); GYRASE INHIBITOR; MAGNESIUM; OFLOXACIN;

ARTICLE; CHEMISTRY; DOSE RESPONSE; DRUG RESISTANCE; ENZYMOLOGY; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; MICROBIOLOGICAL EXAMINATION; TRICHOMONAS VAGINALIS;

ADENOSINE TRIPHOSPHATE; AMSACRINE; CHROMATOGRAPHY, LIQUID; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; MAGNESIUM; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; TOPOISOMERASE II INHIBITORS; TRICHOMONAS VAGINALIS;

EID: 70349789723     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Arthan D, Sithiprom S, Thima K, Limmatvatirat C, Chavalitshewinkoon- Petmitr P, Svasti J. Inhibitory effects of Thai plants beta-glycosides on Trichomonas vaginalis. Parasitol Res 2008; 103: 443-8.
2. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
3. Chavalitshewinkoon-Petmitr P, Ramdja M, Kajorndechakiat S. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors. Southeast Asian J Trop Med Public Health 2000; 31: 118-22.
4. Cotch MF, Pastorek JG, Nugent RP, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex Transm Dis 1997; 24: 353-60.
5. Diamond LS. The establishment of various trichomonads of animals and man in axenic cultures. J Parasitol 1957; 43: 488-90.
6. Giles GI, Sharma RP. Topoisomerase enzymes as therapeutic targets for cancer chemotherapy. Med Chem 2005; 1: 383-4.
7. Halligan BD, Edwards KA, Liu LF. Purification and characterization of a type II DNA topoisomerase from bovine calf thymus. J Biol Chem 1985; 260: 2475-82.
8. Hollander DH. Colonial morphology of Trichomonas vaginalis in agar. J Parasitol 1976; 62: 826-8.
9. Johnson PJ, Lahti CJ, Bradley PJ. Biogenesis of the hydrogenosome in the anaerobic protist Trichomonas vaginalis. J Parasitol 1993; 79: 664-70.
10. Kissinger P, Secor WE, Leichliter JS, et al. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis 2008; 46: 994-9.
11. Klebanoff MA, Carey JC, Hauth JC, et al. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001; 345: 487-93.
12. Miller KG, Liu LF, Englund PT. A homogeneous type II DNA topoisomerase from HeLa cell nuclei. J Biol Chem 1981; 256: 9334-9.
13. Moodley P, Connolly C, Sturm AW. Interrelationships among human immunodeficiency virus type I infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J Infect Dis 2002a; 185: 69-73.
14. Moodley P, Wilkinson D, Connolly C, Moodley J, Sturm AW. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin Infect Dis 2002b; 34: 519-22.
15. Nitiss JL, Zhou J, Rose A, Hsiung Y, Gale KC, Osheroff N: The bis (naphthalimide) DMP-840 causes cytotoxicity by its action against eukaryotic topoisomerase II. Biochemistry 1998; 37: 3078-85.
16. Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11: 300-17.
17. Riou JF, Gabillot M, Philippe M, Schrevel J, Riou G. Purification and characterization of Plasmodium berghei DNA topoisomerases I and II: drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry 1986; 25: 1471-9.
18. Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001; 46: 545-9.
19. Schomburg U, Grosse F. Purification and characterization of DNA topoisomerase II from calf thymus associated with polypeptides of 175 and 150 kDa. Eur J Biochem 1986; 160: 451-7.
20. Schwebke J, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006; 50: 4209-10.
21. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding Trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microb Rev 2009; 22: 37-45.
22. Shelton ER, Osheroff N, Brutlag DL. DNA topoisomerase II from Drosophila melanogaster. purification and physical characterization. J Biol Chem 1983; 258: 9530-5.
23. Sobel JD, Nagappan V, Nyirjesy P. Metronidazole-resistant vaginal trichomoniasis: an emerging problem. N Engl J Med 1999; 341: 292-3.
24. Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis 2001; 7: 927-32.
25. Tachezy J, Kulda J, Tomkova E. Aerobic resistance of Trichomonas vaginalis to metronidazole induced in vitro. Parasitology 1993; 106: 31-7.
26. Tse-Dinh YC. Bacterial topoisomerase I as a target for discovery of antibacterial compounds. Nucleic Acids Res 2009; 37: 731-7.
27. Upcroft JA, Dunn LA, Wright JM, Benakli K, Upcroft P, Vanelle P. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob Agents Chemother 2006; 50: 344-7.
28. Wang JC. DNA toposiomerases. Annu Rev Biochem 1985; 54: 665-97.
29. Wang X, Watt PM, Louis EJ, Borts RH, Hickson ID. Part 1: a topoisomerase II-associated protein required for faithful chromosome transmission in Saccharomyces cerevisiae. Nucleic Acids Res 1996; 24: 4791-7.
30. West KL, Austin CA. Human DNA topoisomerase IIβ binds and cleaves four-way junction DNA in vitro. Nucleic Acids Res 1999; 27: 984-92.